GB201615282D0 - Tankyrase inhibitors - Google Patents

Tankyrase inhibitors

Info

Publication number
GB201615282D0
GB201615282D0 GBGB1615282.9A GB201615282A GB201615282D0 GB 201615282 D0 GB201615282 D0 GB 201615282D0 GB 201615282 A GB201615282 A GB 201615282A GB 201615282 D0 GB201615282 D0 GB 201615282D0
Authority
GB
United Kingdom
Prior art keywords
tankyrase inhibitors
tankyrase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1615282.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bath
Original Assignee
University of Bath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Bath filed Critical University of Bath
Priority to GBGB1615282.9A priority Critical patent/GB201615282D0/en
Publication of GB201615282D0 publication Critical patent/GB201615282D0/en
Priority to PCT/GB2017/052624 priority patent/WO2018046933A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1615282.9A 2016-09-08 2016-09-08 Tankyrase inhibitors Ceased GB201615282D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1615282.9A GB201615282D0 (en) 2016-09-08 2016-09-08 Tankyrase inhibitors
PCT/GB2017/052624 WO2018046933A1 (en) 2016-09-08 2017-09-08 Tankyrase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1615282.9A GB201615282D0 (en) 2016-09-08 2016-09-08 Tankyrase inhibitors

Publications (1)

Publication Number Publication Date
GB201615282D0 true GB201615282D0 (en) 2016-10-26

Family

ID=57234618

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1615282.9A Ceased GB201615282D0 (en) 2016-09-08 2016-09-08 Tankyrase inhibitors

Country Status (2)

Country Link
GB (1) GB201615282D0 (en)
WO (1) WO2018046933A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722484B2 (en) 2016-03-09 2020-07-28 K-Gen, Inc. Methods of cancer treatment
WO2019084060A1 (en) 2017-10-24 2019-05-02 Silverback Therapeutics, Inc. Conjugates and methods of use thereof for selective delivery of immune-modulatory agents
KR20200103760A (en) 2017-12-21 2020-09-02 리본 테라퓨틱스 인코포레이티드 Quinazolinones as PARP14 inhibitors
AU2019209960B2 (en) 2018-01-20 2023-11-23 Sunshine Lake Pharma Co., Ltd. Substituted aminopyrimidine compounds and methods of use
US20230158028A1 (en) * 2020-04-06 2023-05-25 The Regents Of The University Of California Compounds and methods for inducing ucp1 expression
WO2021257857A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Naphthyridinone compounds as jak2 v617f inhibitors
US11753413B2 (en) 2020-06-19 2023-09-12 Incyte Corporation Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
WO2022006456A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic pyridone compounds as jak2 v617f inhibitors
AU2021300429A1 (en) 2020-07-02 2023-02-16 Incyte Corporation Tricyclic urea compounds as JAK2 V617F inhibitors
US11661422B2 (en) 2020-08-27 2023-05-30 Incyte Corporation Tricyclic urea compounds as JAK2 V617F inhibitors
CN112375066B (en) * 2020-09-30 2022-05-27 大连理工大学 1, 8-naphthalic anhydride derivatives containing 8- (benzoylamino) quinoline and synthesis and application thereof
US11919908B2 (en) 2020-12-21 2024-03-05 Incyte Corporation Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
TW202302589A (en) 2021-02-25 2023-01-16 美商英塞特公司 Spirocyclic lactams as jak2 v617f inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2890696A1 (en) * 2012-08-29 2015-07-08 Amgen, Inc. Quinazolinone compounds and derivatives thereof
EP3027598B1 (en) * 2013-07-31 2017-04-12 Merck Patent GmbH Oxoquinazolinyl-butanamide derivatives
DK3044221T3 (en) * 2013-09-11 2018-04-23 Institute Of Cancer Res Royal Cancer Hospital The 3-ARYL-5-SUBSTITUTED-ISOQUINOLIN-1-ON COMPOUNDS AND THERAPEUTIC APPLICATION THEREOF

Also Published As

Publication number Publication date
WO2018046933A1 (en) 2018-03-15

Similar Documents

Publication Publication Date Title
IL287113A (en) Smyd inhibitors
HK1243326A1 (en) Bromodomain inhibitors
IL259560A (en) Inhibitors of the menin-mll interaction
ME03759B (en) Bromodomain inhibitors
GB201615282D0 (en) Tankyrase inhibitors
HK1243415A1 (en) Bromodomain inhibitors
IL248895A0 (en) Phosphatidylinositol -kinase inhibitors
IL265139B (en) Dopamine-b-hydroxylase inhibitors
HK1243948A1 (en) Bromodomain inhibitor
DK3398277T3 (en) Random access-procedure
ZA201907136B (en) Ip6k inhibitors
GB201612860D0 (en) Inhibitors
GB201501004D0 (en) Inhibitors
HK1252767A1 (en) Pyrazol-pyridine derivatives as eaat3 inhibitors
HK1250926A1 (en) Inhibitors and their uses
EP3201181A4 (en) Sphingosine kinase inhibitors
IL274550A (en) Dopamine-b-hydroxylase inhibitors
EP3525786A4 (en) Kdm5 inhibitors
GB201520949D0 (en) Inhibitors
ZA201807614B (en) Bromodomain inhibitors
GB201721465D0 (en) Inhibitors
GB201720189D0 (en) Dopamine-B-hydroxylase inhibitors
EP3525785A4 (en) Kdm5 inhibitors
GB201614783D0 (en) Kinases inhibitors
GB201519382D0 (en) Kinase inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)